2022
Pacific Edge Opens Upgraded Dunedin Laboratory
Pacific Edge is pleased to announce the opening of its upgraded clinical laboratory at the University of Otago’s Centre for Innovation in Dunedin.
The new lab, opened by Dunedin MP David Clark on Friday, is designed to future proof Pacific Edge’s diagnostic testing and research and development capabilities. It also provides space for the expected increase in test volumes from the Asia Pacific region and for the evolution of Pacific Edge’s cancer diagnostic technologies.
Pacific Edge CEO, Dr Peter Meintjes, said: “The upgrade – the first since the laboratory was opened in 2011 – highlights our confidence in Cxbladder becoming embedded as the standard of care for the diagnosis and management of urothelial cancer in the Asia Pacific and further afield.”
“It gives us the space to expand testing capacity as the volume of tests from the Asia Pacific rises, supports the implementation of anticipated commercial tests as they emerge from research and development, and provides our team with a better working environment.”
“The upgrade also provides redundancy for our CLIA certified Laboratory in Hershey, Pennsylvania. It’s great to be able to give our customers and partners around the world that level of assurance and I know our team are also looking forward to getting into new digs.”
The upgraded lab has been designed to enhance Cxbladder testing protocols and workflow automation, supporting the continued development of the test, while driving efficiency and adherence to strict quality controls. Additionally, it’s supported by Pacific Edge’s dedicated Laboratory Information Management System, which underpins the integrity of our testing procedure and protects patient samples and identities.
The lab retains its CLIA certification which enables the laboratory to process samples originating from patients within the United States or its territories. It will also retain its ISO-15189 accredited medical laboratory certification.
« Back